Fulcrum Therapeutics, Inc. Profile Avatar - Palmy Investing

Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candida…

Biotechnology
US, Cambridge [HQ]

Lobbying Analysis

Fulcrum Therapeutics, Inc. has no lobbying expenses in our database.

History

Download
FY Quarter Expense For Lobby Disclosure LDA Reference
No data
End of FULC's Analysis
CIK: 1680581 CUSIP: 359616109 ISIN: US3596161097 LEI: - UEI: -
Secondary Listings
FULC has no secondary listings inside our databases.